| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |